Literature DB >> 22572023

Chronic folic acid administration confers no treatment effects in either a high or low dose following unilateral controlled cortical impact injury in the rat.

Cole Vonder Haar1, Michael A Emery, Michael R Hoane.   

Abstract

PURPOSE: Traumatic brain injury (TBI) is a major health concern today and effective treatments must be developed in order to combat the numerous TBIs that occur each year. Multiple b-vitamins have been shown to have neuroprotective effects, however, folic acid (B9) has not been widely studied. The current study examined two different doses in a rodent model of controlled cortical impact (CCI) TBI.
METHODS: Sham procedures or a unilateral parietal controlled cortical impact injury was induced. Rats were administered either vehicle or folic acid in an 80 μg/kg or 800 μg/kg dose. Rats were tested on the bilateral tactile adhesive removal task, rotarod task and the Morris water maze. Brains were examined to determine lesion size and neuronal loss.
RESULTS: Neither of the folic acid-treated groups showed improvement on any behavioral task or anatomical measure post-CCI and the high dose group had increased neuronal loss compared to the vehicle. Administration of the high dose in sham animals resulted in some behavioral dysfunction and significant neuronal loss.
CONCLUSIONS: The results from this study suggest that folic acid may not represent an effective avenue for treatment and that higher doses may actually be detrimental following TBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572023     DOI: 10.3233/RNN-2012-110196

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  8 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Comparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.

Authors:  Cole Vonder Haar; Gail D Anderson; Brandy E Elmore; Lynn H Moore; Amanda M Wright; Eric D Kantor; Fred M Farin; Theo K Bammler; James W MacDonald; Michael R Hoane
Journal:  J Neurotrauma       Date:  2014-01-20       Impact factor: 5.269

3.  Unilateral parietal brain injury increases risk-taking on a rat gambling task.

Authors:  Jenny E Ozga-Hess; Cory Whirtley; Christopher O'Hearn; Kristen Pechacek; Cole Vonder Haar
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

4.  Protective Role of Apocynin via Suppression of Neuronal Autophagy and TLR4/NF-κB Signaling Pathway in a Rat Model of Traumatic Brain Injury.

Authors:  Yan Feng; Changmeng Cui; Xin Liu; Qiang Wu; Fuguang Hu; Haofeng Zhang; Zhizhao Ma; Liqun Wang
Journal:  Neurochem Res       Date:  2017-08-07       Impact factor: 3.996

Review 5.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

Review 6.  Current and Potential Pharmacologic Therapies for Traumatic Brain Injury.

Authors:  Jowy Tani; Ya-Ting Wen; Chaur-Jong Hu; Jia-Ying Sung
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-06

Review 7.  Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side.

Authors:  Alice Jacquens; Edward J Needham; Elisa R Zanier; Vincent Degos; Pierre Gressens; David Menon
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

8.  Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats.

Authors:  Yan Feng; Yaru Ju; Jianzhong Cui; Liqun Wang
Journal:  Mol Med Rep       Date:  2017-05-25       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.